US6991907B1
(en)
*
|
1995-04-18 |
2006-01-31 |
Biosite, Inc. |
Methods for the assay of troponin I and T and complexes of troponin I and T and selection of antibodies for use in immunoassays
|
US6627404B1
(en)
*
|
1995-04-18 |
2003-09-30 |
Biosite, Inc. |
Methods for improving the recovery of troponin I and T in membranes, filters and vessels
|
DE19847690A1
(de)
|
1998-10-15 |
2000-04-20 |
Brahms Diagnostica Gmbh |
Verfahren und Substanzen für die Diagnose und Therapie von Sepsis und sepsisähnlichen systemischen Infektionen
|
AU2002218026A1
(en)
|
2000-11-09 |
2002-05-21 |
The Brigham And Women's Hospital, Inc. |
Cardiovascular disease diagnostic and therapeutic targets
|
US7645739B2
(en)
|
2001-02-21 |
2010-01-12 |
Alavita Pharmaceuticals, Inc. |
Modified annexin compositions and methods of using same
|
US7635680B2
(en)
|
2001-02-21 |
2009-12-22 |
Alavita Pharmaceuticals, Inc. |
Attenuation of reperfusion injury
|
US7635676B2
(en)
|
2001-02-21 |
2009-12-22 |
Alavita Pharmaccuticals, Inc. |
Modified annexin proteins and methods for their use in organ transplantation
|
US7713705B2
(en)
|
2002-12-24 |
2010-05-11 |
Biosite, Inc. |
Markers for differential diagnosis and methods of use thereof
|
US7524635B2
(en)
*
|
2003-04-17 |
2009-04-28 |
Biosite Incorporated |
Methods and compositions for measuring natriuretic peptides and uses thereof
|
US20040253637A1
(en)
*
|
2001-04-13 |
2004-12-16 |
Biosite Incorporated |
Markers for differential diagnosis and methods of use thereof
|
US7632647B2
(en)
*
|
2001-04-13 |
2009-12-15 |
Biosite Incorporated |
Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes
|
US20030219734A1
(en)
*
|
2001-04-13 |
2003-11-27 |
Biosite Incorporated |
Polypeptides related to natriuretic peptides and methods of their identification and use
|
US20030199000A1
(en)
*
|
2001-08-20 |
2003-10-23 |
Valkirs Gunars E. |
Diagnostic markers of stroke and cerebral injury and methods of use thereof
|
US20040176914A1
(en)
*
|
2001-04-13 |
2004-09-09 |
Biosite Incorporated |
Methods and compositions for measuring biologically active natriuretic peptides and for improving their therapeutic potential
|
JP2005522669A
(ja)
*
|
2001-08-20 |
2005-07-28 |
バイオサイト インコーポレイテッド |
卒中および脳損傷の診断マーカーおよびその使用方法
|
US20040209307A1
(en)
*
|
2001-08-20 |
2004-10-21 |
Biosite Incorporated |
Diagnostic markers of stroke and cerebral injury and methods of use thereof
|
US7608406B2
(en)
|
2001-08-20 |
2009-10-27 |
Biosite, Inc. |
Diagnostic markers of stroke and cerebral injury and methods of use thereof
|
US20040219509A1
(en)
*
|
2001-08-20 |
2004-11-04 |
Biosite, Inc. |
Diagnostic markers of stroke and cerebral injury and methods of use thereof
|
US6461828B1
(en)
|
2001-09-04 |
2002-10-08 |
Syn X Pharma |
Conjunctive analysis of biological marker expression for diagnosing organ failure
|
CA2484897C
(en)
|
2002-05-09 |
2015-10-06 |
The Brigham And Women's Hospital, Inc. |
Soluble st2 as a cardiovascular disease marker and therapeutic target
|
MXPA03004105A
(es)
|
2002-05-14 |
2004-10-15 |
Hoffmann La Roche |
Elaboracion de una prognosis en casos de enfermedad cardiaca usando una combinacion de marcadores.
|
JP5179011B2
(ja)
*
|
2002-10-09 |
2013-04-10 |
ディーエムアイ バイオサイエンシズ インコーポレイテッド |
胎盤虚血および多臓器不全のモニタリング
|
SG159387A1
(en)
*
|
2002-11-26 |
2010-03-30 |
Biocon Ltd In |
Modified natriuretic compounds, conjugates, and uses thereof
|
GB0229747D0
(en)
*
|
2002-12-20 |
2003-01-29 |
Axis Shield Asa |
Assay
|
EP1587955A4
(de)
*
|
2002-12-24 |
2007-03-14 |
Biosite Inc |
Differenzialdiagnose-marker und verfahren zu ihrer verwendung
|
DK1616184T4
(en)
*
|
2003-03-27 |
2018-08-13 |
Childrens Hospital Med Ct |
Method and kit for detecting early onset of renal tubular cell damage
|
DE10316583A1
(de)
|
2003-04-10 |
2004-10-28 |
B.R.A.H.M.S Aktiengesellschaft |
Bestimmung eines midregionalen Proadrenomedullin-Teilpeptids in biologischen Flüssigkeiten zu diagnostischen Zwecken, sowie Immunoassays für die Durchführung einer solchen Bestimmung
|
EP1616181B1
(de)
|
2003-04-17 |
2009-08-12 |
Vermillion, Inc. |
Mit natriuretischen peptiden verwandte polypeptide und verfahren zu ihrer identifizierung und verwendung
|
WO2004097368A2
(en)
*
|
2003-04-28 |
2004-11-11 |
Ciphergen Biosystems, Inc. |
Improved immunoassays
|
WO2004105575A2
(en)
*
|
2003-05-29 |
2004-12-09 |
Trustee Of Darmouth College |
A method for detecting cardiac ischemia via changes in b-natriuretic peptide levels
|
US20050148029A1
(en)
*
|
2003-09-29 |
2005-07-07 |
Biosite, Inc. |
Methods and compositions for determining treatment regimens in systemic inflammatory response syndromes
|
CA2537668A1
(en)
*
|
2003-09-29 |
2005-04-14 |
Biosite Incorporated |
Methods and compositions for the diagnosis of sepsis
|
DE10351238A1
(de)
*
|
2003-11-03 |
2005-06-02 |
Roche Diagnostics Gmbh |
Diagnosestellung von akuten myokardialen, ischämischen Erkrankungen durch Kombination von Markern
|
EP1530047A1
(de)
*
|
2003-11-07 |
2005-05-11 |
Roche Diagnostics GmbH |
Proximale Markermoleküle der Arterienthrombose und der Entzündung zur Risikostratifizierung einer koronaren Herzkrankheit
|
WO2005047882A2
(en)
*
|
2003-11-07 |
2005-05-26 |
Princeton Biochemicals, Inc. |
Multi-dimensional electrophoresis apparatus
|
US20050196817A1
(en)
*
|
2004-01-20 |
2005-09-08 |
Molecular Staging Inc. |
Biomarkers for sepsis
|
US20050181451A1
(en)
*
|
2004-02-12 |
2005-08-18 |
Bates Harold M. |
Detection of asymptomatic coronary artery disease using atherogenic proteins and acute phase reactants
|
US20080175191A1
(en)
*
|
2004-02-23 |
2008-07-24 |
Siemens Aktiengesellschaft |
Method, Intermediate Station and Central Control Unit For the Packet-Switched Data Transmission in a Self-Organizing Radio Network
|
US20050244892A1
(en)
*
|
2004-02-27 |
2005-11-03 |
Lazar Mitchell A |
Resistin as a marker and therapeutic target for cardiovascular disease
|
WO2005099744A1
(en)
*
|
2004-04-15 |
2005-10-27 |
Athera Biotechnologies Ab |
Annexin v for preventing atherothrombois and plaque rupture
|
US20050272101A1
(en)
*
|
2004-06-07 |
2005-12-08 |
Prasad Devarajan |
Method for the early detection of renal injury
|
DE102004028303A1
(de)
|
2004-06-11 |
2005-12-29 |
Roche Diagnostics Gmbh |
Verfahren und Vorrichtung zum Nachweis von Analyten
|
EP1759214B1
(de)
|
2004-06-15 |
2013-04-24 |
F.Hoffmann-La Roche Ag |
Verwendung von herzhormonen zur diagnose des risikos, eine kardiovaskuläre komplikation als folge einer kardiotoxischen medikation zu erleiden
|
EP1615035B1
(de)
*
|
2004-07-07 |
2007-06-06 |
F.Hoffmann-La Roche Ag |
Kombinationen von Markern zum Nachweis von typ 1 und 2 Diabetes
|
ES2818028T3
(es)
*
|
2004-12-20 |
2021-04-09 |
Antibodyshop As |
Determinación de lipocalina asociada a gelatinasa de neutrófilos (NGAL) como marcador diagnóstico para trastornos renales
|
US20080050832A1
(en)
*
|
2004-12-23 |
2008-02-28 |
Buechler Kenneth F |
Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes
|
WO2006076471A2
(en)
*
|
2005-01-12 |
2006-07-20 |
Nobex Corporation |
Bnp conjugates and methods of use
|
CA2595794A1
(en)
|
2005-01-24 |
2006-07-27 |
F. Hoffmann-La Roche Ag |
The use of cardiac hormones for assessing a cardiovascular risk with respect to the administration of anti-inflammatory drugs
|
US7432107B2
(en)
|
2005-01-24 |
2008-10-07 |
Roche Diagnostics Operations, Inc. |
Cardiac hormones for assessing cardiovascular risk
|
EP1691200A1
(de)
*
|
2005-02-14 |
2006-08-16 |
F. Hoffmann-La Roche Ag |
Verwendung des BNP-Art und ANP-Art Peptiden für das Festsetzen der Gefahren von Herzgefäß- Komplikationen als Folge der Volumenüberlastung
|
DE102005003687A1
(de)
*
|
2005-01-26 |
2006-07-27 |
Sphingo Tec Gmbh |
Immunoassay zur Bestimmung der Freisetzung von Neurotensin in die Zirkulation
|
US8900815B2
(en)
|
2005-02-21 |
2014-12-02 |
Saga University |
Platelet-derived microparticles as a novel diagnosis maker for a cardiovascular disease
|
US20060199280A1
(en)
*
|
2005-03-03 |
2006-09-07 |
David Bar-Or |
Quantification of proteins
|
US20070037232A1
(en)
*
|
2005-03-31 |
2007-02-15 |
Barasch Jonathan M |
Detection of NGAL in chronic renal disease
|
US20060240444A1
(en)
*
|
2005-04-21 |
2006-10-26 |
Peiguo Chu |
Detection methods
|
US7300631B2
(en)
*
|
2005-05-02 |
2007-11-27 |
Bioscale, Inc. |
Method and apparatus for detection of analyte using a flexural plate wave device and magnetic particles
|
CN100422742C
(zh)
*
|
2005-05-16 |
2008-10-01 |
艾博(武汉)生物技术有限公司 |
急性心肌梗死早期诊断三合一检测试剂板
|
WO2007005426A2
(en)
*
|
2005-06-29 |
2007-01-11 |
Rules-Based Medicine, Inc. |
Methods and kits for the diagnosis of acute coronary syndrome
|
ES2288358B1
(es)
*
|
2005-07-01 |
2008-11-16 |
Proyecto De Biomedicina Cima, S.L. |
Marcadores de fibrosis.
|
JP4850001B2
(ja)
*
|
2005-09-05 |
2012-01-11 |
プリマハム株式会社 |
新規ストレスバイオマーカー及びその用途
|
EP1931990A4
(de)
*
|
2005-10-03 |
2010-03-10 |
Biosite Inc |
Verfahren und zusammensetzungen zur diagnose und/oder prognose bei systemischen inflammatorischen response-syndromen
|
IL172297A
(en)
|
2005-10-03 |
2016-03-31 |
Compugen Ltd |
Soluble vegfr-1 variants for the diagnosis of preeclampsia
|
US20080090304A1
(en)
*
|
2006-10-13 |
2008-04-17 |
Barasch Jonathan Matthew |
Diagnosis and monitoring of chronic renal disease using ngal
|
US7399598B2
(en)
*
|
2005-10-14 |
2008-07-15 |
Taipei Medical University |
Diagnosis method of endometriosis by detecting biochemical markers and usage of these biochemical markers
|
US20110076255A1
(en)
*
|
2005-11-07 |
2011-03-31 |
Pecora Andrew L |
Compositions and methods for treating progressive myocardial injury due to a vascular insufficiency
|
JP2007131548A
(ja)
*
|
2005-11-08 |
2007-05-31 |
Hirosaki Univ |
プロテオグリカンの新規医薬用途
|
US8409810B2
(en)
|
2005-11-17 |
2013-04-02 |
Biogen Idec Ma Inc. |
Platelet aggregation assays using a CD40L-binding agent
|
US9829494B2
(en)
*
|
2005-12-01 |
2017-11-28 |
Adrenomed Ag |
Methods of treatment using ADM antibodies
|
US8906857B2
(en)
*
|
2005-12-01 |
2014-12-09 |
B.R.A.H.M.S. Gmbh |
Methods for the diagnosis and treatment of critically ill patients with endothelin, endothelin agonists and adrenomedullin antagonists
|
GB0601058D0
(en)
*
|
2006-01-19 |
2006-03-01 |
Univ Southampton |
Mast Cell Carboxypeptidase As A Marker For Anaphylaxis And Mastocytosis
|
US20070172888A1
(en)
*
|
2006-01-25 |
2007-07-26 |
Klaus Hallermayer |
Measuring troponin antibodies to assess cardiovascular risk
|
EP2005168A4
(de)
*
|
2006-03-09 |
2009-05-20 |
Biosite Inc |
Verfahren und zusammensetzung zur diagnose von krankheiten der aorta
|
ES2344993T3
(es)
*
|
2006-03-24 |
2010-09-13 |
F. Hoffmann-La Roche Ag |
Medios y metodos para la diferenciacion de la necrosis de miocardio aguda y cronica en pacientes sintomaticos.
|
US7838250B1
(en)
|
2006-04-04 |
2010-11-23 |
Singulex, Inc. |
Highly sensitive system and methods for analysis of troponin
|
AU2007233320B2
(en)
*
|
2006-04-04 |
2013-12-12 |
Singulex, Inc. |
Highly sensitive system and methods for analysis of troponin
|
AU2014200749B2
(en)
*
|
2006-04-04 |
2016-04-14 |
Singulex, Inc. |
Highly sensitive system and methods for analysis of troponin
|
JP6325022B2
(ja)
*
|
2006-04-04 |
2018-05-16 |
シングレックス,インコーポレイテッド |
トロポニンの分析のための高感度のシステムおよび方法
|
EP1845379A1
(de)
|
2006-04-13 |
2007-10-17 |
F. Hoffmann-La Roche AG |
Mittel und Verfahren zur Differenzierung kardialer und pulmonaler Ursachen von Atemnot
|
ATE473448T1
(de)
*
|
2006-04-24 |
2010-07-15 |
Univ Wien Med |
Verfahren zur diagnose von herz-kreislauf- krankheiten
|
EP3255432B1
(de)
|
2006-04-24 |
2019-01-23 |
Critical Care Diagnostics, Inc. |
Vorhersage von letalität und detektion von schweren erkrankungen
|
JP5377289B2
(ja)
*
|
2006-05-01 |
2013-12-25 |
クリティカル ケア ダイアグノスティクス インコーポレイテッド |
心血管疾患の診断方法
|
HUE025058T2
(en)
*
|
2006-05-02 |
2016-01-28 |
Critical Care Diagnostics Inc |
Differential diagnosis of pulmonary and cardiovascular disease
|
US20080118924A1
(en)
*
|
2006-05-26 |
2008-05-22 |
Buechler Kenneth F |
Use of natriuretic peptides as diagnostic and prognostic indicators in vascular diseases
|
ATE539351T1
(de)
|
2006-05-30 |
2012-01-15 |
Antibodyshop As |
Verfahren zur schnellen beurteilung der schwere eines traumas
|
US7935498B2
(en)
*
|
2006-07-07 |
2011-05-03 |
Siemens Healthcare Diagnostics Inc. |
Methods for identifying patients with increased risk of an adverse cardiovascular event
|
EP1882945A1
(de)
|
2006-07-28 |
2008-01-30 |
F.Hoffmann-La Roche Ag |
Vorrichtungen und Verfahren zur Differentierung zwischen herz- und lungenbedingten Ursachen für akute Atemnot
|
ATE511656T1
(de)
|
2006-08-04 |
2011-06-15 |
Hannover Med Hochschule |
Verfahren zur risikobewertung von herzeingriffen auf gdf-15-basis
|
US20100210031A2
(en)
*
|
2006-08-07 |
2010-08-19 |
Antibodyshop A/S |
Diagnostic Test to Exclude Significant Renal Injury
|
EP1890153A1
(de)
|
2006-08-16 |
2008-02-20 |
F. Hoffman-la Roche AG |
Herztroponin als Indikator für fortgeschrittene Koronararterienerkrankung
|
US20080050749A1
(en)
*
|
2006-08-17 |
2008-02-28 |
Ildiko Amann-Zalan |
Use of bnp-type peptides for the stratification of therapy with erythropoietic stimulating agents
|
US8158374B1
(en)
|
2006-09-05 |
2012-04-17 |
Ridge Diagnostics, Inc. |
Quantitative diagnostic methods using multiple parameters
|
ATE449966T1
(de)
|
2006-09-15 |
2009-12-15 |
Hoffmann La Roche |
Biochemische marker für akute lungenembolie
|
EP1901073A1
(de)
|
2006-09-18 |
2008-03-19 |
Roche Diagnostics GmbH |
Natriuretische Peptide zur Diagnose von Herzkomplikationen infolge von Koronarkatheterisierung
|
ES2350255T3
(es)
*
|
2006-09-20 |
2011-01-20 |
Roche Diagnostics Gmbh |
Los péptidos natriuréticos y el factor de crecimiento placentario/receptor soluble de vegf discriminan la disfunción cardíaca relacionada con una enfermedad cardíaca con respecto a una disfunción cardíaca asociada a la placenta en la mujer gestante.
|
DE112007003185A5
(de)
|
2006-10-26 |
2009-10-01 |
Brahms Aktiengesellschaft |
Risikostratifizierung des akuten Koronarsyndroms mittels Fragmenten / Teilpeptiden des proVasopressins, insbesondere Copeptin oder Neurophysin II
|
WO2008060607A2
(en)
*
|
2006-11-14 |
2008-05-22 |
Biosite Incorporated |
Methods and compositions for monitoring and risk prediction in cardiorenal syndrome
|
WO2008061149A2
(en)
*
|
2006-11-14 |
2008-05-22 |
Biosite Incorporated |
Methods and compositions for diagnosis and prognosis of renal artery stenosis
|
EP1925943A1
(de)
|
2006-11-21 |
2008-05-28 |
F. Hoffman-la Roche AG |
Vorrichtungen und Verfahren zur Optimierung von diagnostischen and therapeutischen Ansätzen für chronische Arterienerkrankungen basierend auf dem Nachweis von Troponin T und NT-proBNP.
|
NZ577992A
(en)
|
2006-11-28 |
2012-09-28 |
Pictor Ltd |
Assay membrane and method of use thereof
|
CA2671298C
(en)
*
|
2007-01-25 |
2020-07-28 |
F. Hoffmann-La Roche Ag |
Use of igfbp-7 in the assessment of heart failure
|
US8568999B2
(en)
|
2007-02-12 |
2013-10-29 |
A1M Pharma Ab |
Diagnosis and treatment of preeclampsia
|
CA2680339C
(en)
*
|
2007-03-08 |
2017-02-28 |
F. Hoffmann-La Roche Ag |
Use of slim-1 in the assessment of heart failure
|
GB0705223D0
(en)
*
|
2007-03-19 |
2007-04-25 |
Univ Sussex |
Method, apparatus and computer program for analysing medical image data
|
CN101680903A
(zh)
*
|
2007-03-21 |
2010-03-24 |
比奥波托诊断股份公司 |
肾损伤的诊断试验
|
US8221995B2
(en)
|
2007-03-23 |
2012-07-17 |
Seok-Won Lee |
Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes
|
US20090004755A1
(en)
*
|
2007-03-23 |
2009-01-01 |
Biosite, Incorporated |
Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes
|
JP5214723B2
(ja)
|
2007-04-30 |
2013-06-19 |
ナノゲン・インコーポレイテッド |
多分析物アッセイ
|
DE102007022367A1
(de)
*
|
2007-05-07 |
2008-11-20 |
B.R.A.H.M.S Ag |
Verfahren zur Bestimmung von aminoterminalen pro-ANP bei übergewichtigen Patienten
|
JP5570415B2
(ja)
*
|
2007-05-08 |
2014-08-13 |
アボット・ラボラトリーズ |
他のペプチド型に対する交差反応性の低いヒトb型ナトリウム利尿ペプチドアッセイ
|
EP1998178A1
(de)
*
|
2007-05-29 |
2008-12-03 |
F. Hoffman-la Roche AG |
H-FABP als Prädiktor für Herzinfarkt
|
CN101896816B
(zh)
*
|
2007-06-22 |
2014-08-20 |
B.R.A.H.M.S有限公司 |
用于检测分析物的方法
|
ATE514091T1
(de)
*
|
2007-08-03 |
2011-07-15 |
Brahms Gmbh |
Verwendung von procalcitonin (pct) zur risikostratifikation und prognose bei patienten mit einer primären nichtinfektiösen krankheit
|
EP2031397A1
(de)
|
2007-08-30 |
2009-03-04 |
F. Hoffmann-La Roche AG |
Surfactantproteine B und D bei der Unterscheidung der Ursachen für Atemnot
|
EP2210111A1
(de)
|
2007-10-10 |
2010-07-28 |
Roche Diagnostics GmbH |
Natriuretisches peptid/troponin-verhältnis zur beurteilung bereits vorhandener myokard-fehlfunktion bei patienten mit akutem koronarsyndrom
|
CN105510601B
(zh)
*
|
2007-11-05 |
2018-04-10 |
北欧生物科技公司 |
用于进行cvd风险评估的生物化学标志物
|
JP2011503587A
(ja)
*
|
2007-11-15 |
2011-01-27 |
バイオポルト ディアグノスティックス エイ/エス |
独特の分子形態を有するタンパク質バイオマーカーの診断における使用
|
AU2008338421A1
(en)
|
2007-12-17 |
2009-06-25 |
Dyax Corp. |
Compositions and methods for treating osteolytic disorders comprising MMP-14 binding proteins
|
JP2011517320A
(ja)
|
2008-03-03 |
2011-06-02 |
ダイアックス コーポレーション |
メタロプロテアーゼ9結合タンパク質およびメタロプロテアーゼ2結合タンパク質
|
US8008445B2
(en)
*
|
2008-03-03 |
2011-08-30 |
Dyax Corp. |
Metalloproteinase 9 binding proteins
|
JP2011513753A
(ja)
*
|
2008-03-05 |
2011-04-28 |
シンギュレックス・インコーポレイテッド |
分子の高感度検出の方法および組成物
|
US7927880B2
(en)
|
2008-05-21 |
2011-04-19 |
Mohan Rajapurkar |
Methods and kit for early detection of acute coronary syndrome and prediction of adverse cardiac events
|
WO2009109982A1
(en)
*
|
2008-03-05 |
2009-09-11 |
Mohan Rajapurkar |
Methods and kit for early detection of acute coronary syndrome and prediction of adverse cardiac events
|
EP2103943A1
(de)
|
2008-03-20 |
2009-09-23 |
F. Hoffman-la Roche AG |
GDF-15 zur Beurteilung eines kardiovaskulären Risikos hinsichtlich Verabreichung von Entzündungshemmern
|
PT2660599E
(pt)
|
2008-04-18 |
2014-11-28 |
Critical Care Diagnostics Inc |
Predição do risco de eventos cardíacos adversos maiores
|
EP2294424A1
(de)
|
2008-05-21 |
2011-03-16 |
F. Hoffmann-La Roche AG |
L-fabp, natriuretische peptide und herztroponin bei individuen, die eine herztherapie benötigen
|
US8497078B2
(en)
|
2008-05-23 |
2013-07-30 |
The Johns Hopkins University |
Biomarkers for myocardial ischemia
|
EP2133696A1
(de)
|
2008-06-10 |
2009-12-16 |
Eberhardt Spanuth |
Sehr geringe Konzentrationen von Troponin I oder T zur Beurteilung eines kardiovaskulären Risikos hinsichtlich der Verabreichung von Entzündungshemmern
|
EP2304438A1
(de)
*
|
2008-06-13 |
2011-04-06 |
F. Hoffmann-La Roche AG |
Beurteilung von komplikationen bei patienten mit typ-1-diabetes
|
WO2010010153A1
(en)
|
2008-07-23 |
2010-01-28 |
F. Hoffmann-La Roche Ag |
Identification of subjects being susceptible to anti-angiogenesis therapy
|
EP2148203A1
(de)
*
|
2008-07-23 |
2010-01-27 |
BRAHMS Aktiengesellschaft |
Azurophili-Granulat-Proteasen als Marker bei Herzkrankheiten
|
JP2011528798A
(ja)
*
|
2008-07-23 |
2011-11-24 |
エフ.ホフマン−ラ ロシュ アーゲー |
抗血管形成療法のモニター
|
JP2011530705A
(ja)
|
2008-08-13 |
2011-12-22 |
エフ.ホフマン−ラ ロシュ アーゲー |
肺塞栓症のためのDダイマー、トロポニン、NT−proBNP
|
WO2010023749A1
(ja)
*
|
2008-08-28 |
2010-03-04 |
株式会社 島津製作所 |
血液試料を用いて心筋虚血状態を評価する方法
|
CA2740736A1
(en)
*
|
2008-10-15 |
2010-04-22 |
Ridge Diagnostics, Inc. |
Human biomarker hypermapping for depressive disorders
|
US20120083421A1
(en)
*
|
2008-10-16 |
2012-04-05 |
The Trustees Of Columbia University In The City Of New York |
Use of urinary ngal to diagnose and monitor hiv-associated nephropathy (hivan)
|
ES2431358T3
(es)
*
|
2008-11-11 |
2013-11-26 |
B.R.A.H.M.S Gmbh |
Pronóstico y evaluación del riesgo en pacientes que padecen insuficiencia cardíaca mediante la determinación de la concentración de ADM
|
WO2010059709A2
(en)
*
|
2008-11-18 |
2010-05-27 |
Ridge Diagnostics, Inc. |
Metabolic syndrome and hpa axis biomarkers for major depressive disorder
|
US8457724B2
(en)
*
|
2008-12-11 |
2013-06-04 |
Siemens Medical Solutions Usa, Inc. |
System for heart performance characterization and abnormality detection
|
WO2010101255A1
(ja)
*
|
2009-03-05 |
2010-09-10 |
味の素株式会社 |
クローン病診断試薬
|
CA2754741C
(en)
*
|
2009-03-11 |
2019-02-12 |
Augurex Life Sciences Corporation |
Compositions and methods for characterizing arthritic conditions
|
WO2010118035A2
(en)
*
|
2009-04-06 |
2010-10-14 |
Ridge Diagnostics, Inc. |
Biomarkers for monitoring treatment of neuropsychiatric diseases
|
EP2425016B1
(de)
|
2009-04-29 |
2015-04-01 |
Academisch Medisch Centrum bij de Universiteit van Amsterdam |
Mittel und verfahren zur bekämpfung, vermeidung und/oder bestimmung von herzinsuffizienz oder einem herzinsuffizienzrisiko
|
US20120303083A1
(en)
*
|
2009-05-26 |
2012-11-29 |
The Johns Hopkins University |
Novel desmin phosphorylation sites useful in diagnosis and intervention of cardiac disease
|
WO2010144358A1
(en)
*
|
2009-06-08 |
2010-12-16 |
Singulex, Inc. |
Highly sensitive biomarker panels
|
WO2010143422A1
(ja)
*
|
2009-06-10 |
2010-12-16 |
国立大学法人 新潟大学 |
腎疾患の検査方法
|
US8889625B2
(en)
*
|
2009-07-10 |
2014-11-18 |
Northwestern University |
Cardioprotective role of hepatic cells and hepatocyte secretory factors in myocardial ischemia
|
BR112012006105A2
(pt)
|
2009-09-17 |
2016-06-07 |
Hoffmann La Roche |
painel de múltiplos marcadores de hipertrofia ventricular esquerda.
|
EP3385716A3
(de)
|
2009-10-21 |
2019-01-09 |
The Scripps Research Institute |
Verfahren zur verwendung nicht seltener zellen zur erkennung seltener zellen
|
EP2498796B1
(de)
|
2009-11-09 |
2017-12-27 |
AAL Scientifics, Inc. |
Behandlung von herzkrankheiten
|
WO2011057251A2
(en)
|
2009-11-09 |
2011-05-12 |
The Brigham And Women's Hospital, Inc. |
Treatment of heart disease
|
JP5728488B2
(ja)
*
|
2009-11-13 |
2015-06-03 |
ビージー メディシン, インコーポレイテッド |
心筋梗塞のリスクファクターおよび予測
|
WO2011063470A1
(en)
|
2009-11-27 |
2011-06-03 |
Baker Idi Heart And Diabetes Institute Holdings Limited |
Lipid biomarkers for stable and unstable heart disease
|
EP3246708A3
(de)
|
2009-12-18 |
2018-01-03 |
Roche Diagnostics GmbH |
Troponins zur prognose von nierenausfall bei herzchirurgiepatienten
|
CN102884428A
(zh)
*
|
2010-01-26 |
2013-01-16 |
里奇诊断学股份有限公司 |
对疾病严重度分级和检测抑郁治疗的多个生物标记组
|
WO2011098519A1
(en)
|
2010-02-12 |
2011-08-18 |
Synlab Medizinisches Versorgungszentrum Heidelberg Gmbh |
Homoarginine as a biomarker for the risk of mortality
|
JP5926722B2
(ja)
*
|
2010-03-24 |
2016-05-25 |
プリールミナ ダイアグノスティックス エービーPreelumina Diagnostics Ab |
子癇前症の初期段階マーカーとしてのHbFおよびA1M
|
AU2011249908A1
(en)
|
2010-05-06 |
2012-11-22 |
Singulex, Inc. |
Methods for diagnosing, staging, predicting risk for developing and identifying treatment responders for rheumatoid arthritis
|
EP2388594A1
(de)
|
2010-05-17 |
2011-11-23 |
Roche Diagnostics GmbH |
Mittel auf GDF-15-Basis sowie Verfahren zur Überlebens- und Genesungsvorhersage bei akuter Entzündung
|
ES2667066T3
(es)
|
2010-05-24 |
2018-05-09 |
The Trustees Of Columbia University In The City Of New York |
Proteínas NGAL mutantes y usos de las mismas
|
US8602996B2
(en)
|
2010-06-01 |
2013-12-10 |
Cardiac Pacemakers, Inc. |
Integrating device-based sensors and bedside biomarker assays to detect worsening heart failure
|
PL2596119T3
(pl)
*
|
2010-07-23 |
2021-12-06 |
Astellas Institute For Regenerative Medicine |
Sposoby wykrywania rzadkich subpopulacji komórek i kompozycje wysoko oczyszczonych komórek
|
CN101942416B
(zh)
*
|
2010-07-23 |
2012-03-28 |
中国医学科学院放射医学研究所 |
抗人心肌肌钙蛋白i特异性单克隆抗体及其制备方法
|
US10161928B2
(en)
*
|
2010-07-26 |
2018-12-25 |
Wellmetris, Llc |
Wellness panel
|
WO2012020045A1
(en)
|
2010-08-10 |
2012-02-16 |
Roche Diagnostics Gmbh |
Method for selecting patients with stable coronary artery disease for pci or medical treatment
|
US8956859B1
(en)
|
2010-08-13 |
2015-02-17 |
Aviex Technologies Llc |
Compositions and methods for determining successful immunization by one or more vaccines
|
EP2367006A1
(de)
|
2010-08-24 |
2011-09-21 |
Roche Diagnostics GmbH |
Mittel und Verfahren auf PLGF-Basis zur Diagnose kardialer Ursachen bei akuten Entzündungen
|
EP2609427B1
(de)
|
2010-08-26 |
2015-01-21 |
Roche Diagnostics GmbH |
Verwendung von Biomarkern bei der Beurteilung des frühen Übergangs von arteriellem Bluthochdruck zu Herzinsuffizienz
|
EP2439535A1
(de)
|
2010-10-07 |
2012-04-11 |
F. Hoffmann-La Roche AG |
Diagnose von Herzerkrankungen im Zusammenhang mit Diabetes und GDF-15 und Troponin als Prädiktor für die Entwicklung von Diabetes mellitus Typ 2
|
EP2447720A1
(de)
|
2010-10-26 |
2012-05-02 |
Roche Diagnostics GmbH |
sFlt1 und Lungenkomplikationen
|
US8868168B2
(en)
|
2010-11-11 |
2014-10-21 |
Siemens Medical Solutions Usa, Inc. |
System for cardiac condition characterization using electrophysiological signal data
|
US8818494B2
(en)
|
2010-11-29 |
2014-08-26 |
Siemens Medical Solutions Usa, Inc. |
System for ventricular function abnormality detection and characterization
|
EP2383579A1
(de)
|
2010-12-17 |
2011-11-02 |
F. Hoffmann-La Roche AG |
sFlt-1, Kardiotroponine und natriuretische Peptide beim Nachweis einer Therapie mit HER-2-Inhibitoren
|
CN103430025B
(zh)
*
|
2011-01-20 |
2017-12-26 |
西瑞斯实验室有限公司 |
检测谷蛋白敏感性和其区分于乳糜泻的方法和装置
|
GB2490652A
(en)
*
|
2011-04-18 |
2012-11-14 |
Microtest Matrices Ltd |
Methods of quantifying antibodies, especially IgE antibodies in a sample
|
WO2012151349A1
(en)
|
2011-05-03 |
2012-11-08 |
Liu Shu Q |
Neuroprotection by hepatic cells and hepatocyte secretory factors
|
US8684942B2
(en)
|
2011-05-25 |
2014-04-01 |
Siemens Medical Solutions Usa, Inc. |
System for cardiac impairment detection based on signal regularity
|
EP2385373A1
(de)
|
2011-07-01 |
2011-11-09 |
F. Hoffmann-La Roche AG |
Natriuretische Peptide bei der Schwangerschaft
|
US20120258477A1
(en)
*
|
2011-07-25 |
2012-10-11 |
Northwestern University |
Fecal neopterin concentration measurement as an indicator of disease activity in inflammatory bowel disease
|
EP2581040A1
(de)
|
2011-10-10 |
2013-04-17 |
Roche Diagnostics GmbH |
TNT-basiertes Herzhypertrophierisiko im Zusammenhang mit physiologischem Training und Führung in Athleten
|
WO2013057135A1
(en)
|
2011-10-17 |
2013-04-25 |
Roche Diagnostics Gmbh |
Troponin and bnp based diagnosis of risk patients and cause of stroke
|
US10314909B2
(en)
|
2011-10-21 |
2019-06-11 |
Dyax Corp. |
Combination therapy comprising an MMP-14 binding protein
|
ES2617211T3
(es)
|
2011-11-16 |
2017-06-15 |
Sphingotec Gmbh |
Ensayos de adrenomedulina y métodos para determinar la adrenomedulina madura
|
JP6224608B2
(ja)
|
2011-11-16 |
2017-11-01 |
アドレノメト アクチェンゲゼルシャフト |
血液循環を安定化させるための、患者の急性疾患又は急性病態の治療法における使用に向けた、抗アドレノメデュリン(ADM)抗体、抗ADM抗体フラグメント又は抗ADM非Ig足場
|
SG10201801919QA
(en)
|
2011-11-16 |
2018-04-27 |
Adrenomed Ag |
Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for prevention or reduction of organ dysfunction or organ failure in a patient having a chronic or acute disease or acute condition
|
SG10201802054TA
(en)
|
2011-11-16 |
2018-05-30 |
Adrenomed Ag |
Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for regulating the fluid balance in a patient having a chronic or acute disease
|
CN107064516B
(zh)
|
2011-12-01 |
2019-08-02 |
霍夫曼-拉罗奇有限公司 |
用于诊断中风的nt-原anp和nt-原bnp
|
CN103163295B
(zh)
*
|
2011-12-08 |
2015-11-18 |
吴宗贵 |
一种用于急性冠脉综合征的液相芯片试剂盒以其制备方法
|
BR112014014456A2
(pt)
*
|
2011-12-15 |
2018-09-25 |
Pronota Nv |
biomarcadores e parâmetros para distúrbios hipertensivos da gravidez
|
JP5814800B2
(ja)
*
|
2011-12-28 |
2015-11-17 |
株式会社Lsiメディエンス |
神経変性疾患の検出方法
|
ES2538226T3
(es)
|
2012-01-26 |
2015-06-18 |
F. Hoffmann-La Roche Ag |
Método para la diferenciación de la insuficiencia cardiaca anterógrada y retrógrada
|
WO2013116544A1
(en)
|
2012-01-31 |
2013-08-08 |
Cardiac Pacemakers, Inc. |
Systems and methods for controlling a cardiac resynchronisation device/therapy using biomarker panel data
|
JP5951804B2
(ja)
*
|
2012-01-31 |
2016-07-13 |
カーディアック ペースメイカーズ, インコーポレイテッド |
移植可能な医療装置及びバイオマーカーパネルデータをcrt後のlvesv低減のリスクの指標とするための方法
|
EP2650684A1
(de)
|
2012-04-10 |
2013-10-16 |
Roche Diagniostics GmbH |
Diagnose auf Pro-SP-B und NT-proBNP bei Patienten mit Lungenentzündung
|
US8903480B2
(en)
|
2012-04-11 |
2014-12-02 |
Siemens Medical Solutions Usa, Inc. |
System for cardiac condition detection using heart waveform area associated analysis
|
CN104428674A
(zh)
*
|
2012-04-24 |
2015-03-18 |
思研(Sri)国际顾问与咨询公司 |
前列腺癌和sar-cov的人血清生物标记物
|
EP2615459A1
(de)
|
2012-04-27 |
2013-07-17 |
Roche Diagniostics GmbH |
Verfahren zur Diagnose von Distalbronchoalveolargewebeschäden in Asthma durch Erkennen von proSP-B
|
WO2013181127A1
(en)
*
|
2012-05-30 |
2013-12-05 |
Clarient Diagnostic Services, Inc. |
Multiplexed assay method for lung cancer classification
|
JPWO2013183725A1
(ja)
*
|
2012-06-06 |
2016-02-01 |
国立大学法人九州大学 |
非ヒトモデル動物、非ヒトモデル動物の作製方法及び抗血栓薬のスクリーニング方法
|
EP2600155A1
(de)
|
2012-06-18 |
2013-06-05 |
Roche Diagniostics GmbH |
sFlt-1-basierte Diagnose und Überwachung von Schlaganfallpatienten
|
EP2597466A1
(de)
|
2012-06-26 |
2013-05-29 |
Roche Diagniostics GmbH |
Mittel und Verfahren zur proSP-B-basierten Diagnose von Alveolenbeschädigung bei Patienten mit pulmonaler Hypertonie
|
EP2597467A1
(de)
|
2012-06-26 |
2013-05-29 |
Roche Diagniostics GmbH |
Mittel und Verfahren zur proSP-B-basierten Diagnose von Lungenstauung bei Patienten mit akutem Koronarsyndrom
|
WO2014009418A1
(en)
|
2012-07-10 |
2014-01-16 |
Roche Diagnostics Gmbh |
TnT, NTproBNP, sFlt-1 for CURB65 IN PNEUMONIA
|
EP2888687B1
(de)
|
2012-08-21 |
2023-08-02 |
Critical Care Diagnostics, Inc. |
Risikostratifizierung auf der basis von mehreren markern
|
ES2913539T3
(es)
*
|
2012-09-12 |
2022-06-02 |
Hoffmann La Roche |
Identificación de pacientes con fracción de acortamiento anómala
|
US9702876B2
(en)
*
|
2012-10-02 |
2017-07-11 |
Sphingotec Gmbh |
Method for predicting the risk of getting cancer or diagnosing cancer in a female subject
|
US20140273273A1
(en)
|
2012-11-01 |
2014-09-18 |
Christie Mitchell Ballantyne |
Biomarkers to improve prediction of heart failure risk
|
EP2730923A1
(de)
|
2012-11-09 |
2014-05-14 |
Roche Diagniostics GmbH |
NTproBNP- und cTnT-basierte Therapieanleitung bei Herzversagen
|
CN104769436B
(zh)
|
2012-11-09 |
2018-01-26 |
霍夫曼-拉罗奇有限公司 |
阵发性心房纤颤的基于TnT的诊断
|
EP2925337B1
(de)
|
2012-11-21 |
2019-07-03 |
The Trustees of Columbia University in the City of New York |
Mutante ngal-proteine und verwendungen davon
|
JP6342914B2
(ja)
|
2012-12-04 |
2018-06-13 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
心不全の治療選択におけるバイオマーカー
|
DE102012223378A1
(de)
*
|
2012-12-17 |
2014-06-18 |
Charité - Universitätsmedizin Berlin |
In-vitro Verfahren und Kit zur Diagnose von akutem Koronarsyndrom
|
WO2014098135A1
(ja)
*
|
2012-12-20 |
2014-06-26 |
国立大学法人北海道大学 |
前立腺基底細胞の検出方法
|
US20160116472A1
(en)
*
|
2013-02-04 |
2016-04-28 |
The General Hospital Corporation |
Biomarkers for stroke diagnosis
|
KR101494882B1
(ko)
*
|
2013-02-21 |
2015-02-25 |
한국과학기술연구원 |
급성 심근 경색 진단용 조성물, 그 조성물을 포함하는 급성 심근 경색 진단용 키트 및 급성 심근 경색 진단 방법
|
US9020583B2
(en)
|
2013-03-13 |
2015-04-28 |
Siemens Medical Solutions Usa, Inc. |
Patient signal analysis and characterization
|
EP2866033A1
(de)
|
2013-10-23 |
2015-04-29 |
Roche Diagniostics GmbH |
Differenzialdiagnose von akuter Atemnot auf Basis von c-terminiertem proSP-B, KL-6 und BNP-Peptiden
|
WO2015066035A1
(en)
*
|
2013-10-28 |
2015-05-07 |
The Forsyth Institute |
Compositions and methods for evaluating metabolic syndrome and related diseases
|
WO2015063248A2
(en)
|
2013-11-04 |
2015-05-07 |
F. Hoffmann-La Roche Ag |
Biomarkers and methods for progression prediction for chronic kidney disease
|
WO2015072865A1
(en)
*
|
2013-11-15 |
2015-05-21 |
Lee Jacqueline Amanda |
Biomarker for cardiac disorders
|
US20160040245A1
(en)
*
|
2014-01-27 |
2016-02-11 |
Epic Sciences, Inc. |
Circulating tumor cell diagnostics for detection of neuroendocrine prostate cancer (nepc)
|
ES2712201T3
(es)
|
2014-01-28 |
2019-05-09 |
Hoffmann La Roche |
Biomarcadores para la evaluación de riesgos y la monitorización del tratamiento en pacientes de insuficiencia cardíaca que han recibido terapia guiada por el péptido natriurético de tipo B
|
EA201691682A1
(ru)
|
2014-02-21 |
2017-02-28 |
Эпик Сайенсиз, Инк. |
Способы анализирования редких циркулирующих в крови клеток
|
EP2916134B1
(de)
|
2014-03-05 |
2017-08-16 |
Roche Diagnostics GmbH |
Verwendung von Seprase zur Differenzialdiagnose von akuter Atemnot
|
EP2924438B1
(de)
|
2014-03-26 |
2018-04-18 |
Roche Diagnostics GmbH |
IGFBP7 zur Diagnose diastolischer Dysfunktion
|
AU2014407088B2
(en)
|
2014-09-26 |
2021-09-23 |
Somalogic Operating Co., Inc. |
Cardiovascular risk event prediction and uses thereof
|
CN107427221B
(zh)
*
|
2015-01-09 |
2021-03-09 |
全球基因集团有限责任公司 |
用于诊断冠状动脉粥样硬化性疾病的基于血液的生物标志物
|
EP3411721A1
(de)
|
2016-02-04 |
2018-12-12 |
Metanomics GmbH |
Mittel und verfahren zur differenzierung zwischen herzinsuffizienz und lungenerkrankung bei einer person
|
WO2017174786A1
(en)
*
|
2016-04-08 |
2017-10-12 |
Lunginnov |
Methods and kits for diagnosing postoperative pulmonary infections in patients who underwent surgery
|
EP3279665B1
(de)
|
2016-08-04 |
2020-07-08 |
Roche Diagniostics GmbH |
Zirkulierende esm-1 (endocan) bei der beurteilung von vorhofflimmern
|
WO2018069487A1
(en)
|
2016-10-14 |
2018-04-19 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and kits for predicting the risk of loss of renal function in patients with type 2 diabetes
|
WO2018127372A1
(en)
|
2016-12-13 |
2018-07-12 |
Witteman Johanna Cornelia Maria |
Detection of transient troponin peaks for diagnosis of subjects at high risk of cardiovascular disease
|
EP3360570A1
(de)
|
2017-02-13 |
2018-08-15 |
Roche Diagnostics GmbH |
Monoklonale antikörper für nt-probnp punktmutationen
|
US20220178945A1
(en)
*
|
2018-03-30 |
2022-06-09 |
Eiken Kagaku Kabushiki Kaisha |
Novel aortic aneurysm marker
|
EP3572813A1
(de)
*
|
2018-05-22 |
2019-11-27 |
Centre National de la Recherche Scientifique |
Diagnoseverfahren von multipler sklerose
|
IT201800007264A1
(it)
*
|
2018-07-17 |
2020-01-17 |
|
Metodo per la diagnosi in vitro di carcinoma della prostata mediante biomarcatori urinari
|
CN113167799A
(zh)
|
2018-07-31 |
2021-07-23 |
豪夫迈·罗氏有限公司 |
循环DKK3(Dickkopf相关蛋白3)在心房颤动评定中的应用
|
JP7389108B2
(ja)
|
2018-08-10 |
2023-11-29 |
エフ. ホフマン-ラ ロシュ アーゲー |
心房細動関連脳卒中の評価のためのces-2(カルボキシルエステラーゼ-2)
|
WO2020035588A1
(en)
|
2018-08-16 |
2020-02-20 |
Roche Diagnostics Gmbh |
Circulating tfpi-2 (tissue factor pathway inhibitor 2) in the assessment of atrial fibrillation and anticoagulation therapy
|
EP3837550A1
(de)
|
2018-08-17 |
2021-06-23 |
Roche Diagnostics GmbH |
Zirkulierendes bmp10 (knochenmorphogenes protein 10) bei der beurteilung von vorhoffflimmern
|
KR20210047304A
(ko)
|
2018-08-22 |
2021-04-29 |
에프. 호프만-라 로슈 아게 |
심방 세동 평가에서 순환 spon-1 (스폰딘-1)
|
JP7451499B2
(ja)
|
2018-08-24 |
2024-03-18 |
エフ. ホフマン-ラ ロシュ アーゲー |
心房細動の判定および脳卒中の予測のための循環fgfbp-1(線維芽細胞成長因子結合タンパク質1)
|
WO2020064995A1
(en)
|
2018-09-28 |
2020-04-02 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Use of biomarkers representing cardiac, vascular and inflammatory pathways for the prediction of acute kidney injury in patients with type 2 diabetes
|
CN111192687A
(zh)
*
|
2018-11-14 |
2020-05-22 |
复旦大学附属儿科医院 |
一种进展期阑尾炎列线图预测模型及其用途
|
CN113939741A
(zh)
|
2019-05-23 |
2022-01-14 |
豪夫迈·罗氏有限公司 |
HFpEF的IGFBP7比率
|
AU2020325285A1
(en)
*
|
2019-08-07 |
2022-02-03 |
Edifice Health, Inc. |
Treatment of prevention of cardiovascular disease
|
JP2023515436A
(ja)
|
2020-02-20 |
2023-04-13 |
ユニベルシテイト マーストリヒト |
循環bmp10(骨形成タンパク質10)の検出方法
|
CN116547537A
(zh)
|
2020-07-29 |
2023-08-04 |
皮克托有限公司 |
SARS-CoV-2抗体免疫测定
|
CN116235056A
(zh)
|
2020-09-30 |
2023-06-06 |
豪夫迈·罗氏有限公司 |
心房颤动评定中的循环总NT-proBNP(糖基化和未糖基化NT-proBNP)及其与NT-proBNP(未糖基化NT-proBNP)的比率
|
CN114182010B
(zh)
*
|
2022-01-11 |
2022-06-07 |
首都医科大学附属北京朝阳医院 |
一种血浆外泌体circRNA标志物及其应用
|
WO2023175176A1
(en)
|
2022-03-18 |
2023-09-21 |
Roche Diagnostics Gmbh |
Cmybpc marker combinations for early discrimination of type 2 versus type 1 acute myocardial infarction
|
WO2023175152A1
(en)
|
2022-03-18 |
2023-09-21 |
Roche Diagnostics Gmbh |
Troponin marker combinations for early discrimination of type 2 versus type 1 acute myocardial infarction
|